123 related articles for article (PubMed ID: 38286026)
1. Exploring Hollow Mesoporous Silica Nanoparticles as a Nanocarrier in the Delivery of Foot-And-Mouth Disease Virus-like Particle Vaccines.
Ru J; Chen Y; Tao S; Du S; Liang C; Teng Z; Gao Y
ACS Appl Bio Mater; 2024 Feb; 7(2):1064-1072. PubMed ID: 38286026
[TBL] [Abstract][Full Text] [Related]
2. Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.
Bai M; Dong H; Su X; Jin Y; Sun S; Zhang Y; Yang Y; Guo H
J Med Virol; 2019 Jun; 91(6):941-948. PubMed ID: 30701562
[TBL] [Abstract][Full Text] [Related]
3.
An W; Defaus S; Andreu D; Rivera-Gil P
Front Immunol; 2021; 12():684612. PubMed ID: 34220835
[TBL] [Abstract][Full Text] [Related]
4. Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs.
Wu P; Zhang Y; Yin X; He Y; Zhang Q; Chen C
BMC Vet Res; 2020 Dec; 16(1):474. PubMed ID: 33276787
[TBL] [Abstract][Full Text] [Related]
5. FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
Bidart J; Mignaqui A; Kornuta C; Lupi G; Gammella M; Soria I; Galarza R; Ferella A; Cardillo S; Langellotti C; Quattrocchi V; Durocher Y; Wigdorovitz A; Marcipar I; Zamorano P
Virus Res; 2021 May; 297():198339. PubMed ID: 33596405
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
Terhuja M; Saravanan P; Tamilselvan RP
Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
[TBL] [Abstract][Full Text] [Related]
7. Bi-functional gold nanocages enhance specific immunological responses of foot-and-mouth disease virus-like particles vaccine as a carrier and adjuvant.
Teng Z; Sun S; Luo X; Zhang Z; Seo H; Xu X; Huang J; Dong H; Mu S; Du P; Zhang Z; Guo H
Nanomedicine; 2021 Apr; 33():102358. PubMed ID: 33484882
[TBL] [Abstract][Full Text] [Related]
8. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable Imiquimod-Loaded Mesoporous Organosilica as a Nanocarrier and Adjuvant for Enhanced and Prolonged Immunity against Foot-and-Mouth Disease Virus in Mice.
Yin W; Xuan D; Wang H; Zhou M; Deng B; Ma F; Lu Y; Zhang J
ACS Appl Bio Mater; 2022 Jun; 5(6):3095-3106. PubMed ID: 35679606
[TBL] [Abstract][Full Text] [Related]
10. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
[TBL] [Abstract][Full Text] [Related]
11. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
12. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.
Dong YM; Cai JC; Chen HT; Chen L
Antiviral Res; 2016 Oct; 134():108-116. PubMed ID: 27565990
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
She X; Chen L; Velleman L; Li C; Zhu H; He C; Wang T; Shigdar S; Duan W; Kong L
J Colloid Interface Sci; 2015 May; 445():151-160. PubMed ID: 25617610
[TBL] [Abstract][Full Text] [Related]
14. Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
Teng Z; Sun S; Chen H; Huang J; Du P; Dong H; Xu X; Mu S; Zhang Z; Guo H
Vaccine; 2018 Oct; 36(45):6752-6760. PubMed ID: 30268733
[TBL] [Abstract][Full Text] [Related]
15. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
[TBL] [Abstract][Full Text] [Related]
16. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
[TBL] [Abstract][Full Text] [Related]
17. Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles.
Lu Y; Dong H; Li J; Li L; Wang M; Liu H; Teng Z; Zhang Y; Jin Y; Guo H; Yang Y; Wen X; Sun S
Microb Pathog; 2020 Jun; 143():104130. PubMed ID: 32165331
[TBL] [Abstract][Full Text] [Related]
18. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
[TBL] [Abstract][Full Text] [Related]
19. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
[TBL] [Abstract][Full Text] [Related]
20. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
Asghar K; Qasim M; Dharmapuri G; Das D
Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
